KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,241,000 | -21.3% | 830,472 | -29.3% | 0.27% | -16.0% |
| Q4 2021 | $15,547,000 | -58.8% | 1,175,131 | -45.7% | 0.33% | -55.8% |
| Q3 2021 | $37,754,000 | -27.2% | 2,163,554 | 0.0% | 0.74% | -20.0% |
| Q2 2021 | $51,839,000 | +97.8% | 2,163,554 | +112.1% | 0.92% | +67.2% |
| Q1 2021 | $26,204,000 | +153.6% | 1,020,005 | +14.5% | 0.55% | +30.9% |
| Q3 2019 | $10,332,000 | -61.7% | 890,668 | -26.9% | 0.42% | -56.6% |
| Q2 2019 | $26,971,000 | +45.0% | 1,217,668 | +87.3% | 0.97% | +35.9% |
| Q1 2019 | $18,603,000 | +44.9% | 650,000 | 0.0% | 0.71% | +38.7% |
| Q4 2018 | $12,838,000 | -10.7% | 650,000 | 0.0% | 0.51% | -0.2% |
| Q3 2018 | $14,372,000 | – | 650,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |